Home > Insider Trading > Filing (0001144204-13-010526)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1091596	Cytomedix Inc	CMXI	Surgical & Medical Instruments & Apparatus (3841)	232958959

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1542363	Joseph Guercio Del	209 Perry Parkway, Suite 7 Gaithersburg MD 20877		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-02-19	509,091	$0.55	1,143,770	No	4	P	Indirect	SEE FOOTNOTE

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	SEE FOOTNOTE

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	COMMON STOCK WARRANT	Acquisiton	2013-02-19	356,364	$0.00	356,364	$0.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
520,362	2013-02-19	2018-02-19	No	4	P	Indirect

Footnotes

The shares of common stock and common stock warrants were acquired and are owned directly by CNF Investments II, LLC. ("CNF") in the February 19, 2013 registered offering of the Company's securities pursuant to the effective registration statement on Form S-3 (the "Reportable Securities"). The individual managing members (collectively, the "CNF Member Managers") of CNF are Joseph Del Guercio and Robert J. Flanagan. CNF and CNF Member Managers may share voting and dispositive power over the shares directly held by CNF. Mr. Del Guercio is Managing Director of CNF. He disclaims beneficial ownership of such securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The Reportable Securities in the above-referenced offering were sold in units, at the price per unit of $.55, with each unit consisting of one share of common stock together with a warrant to purchase 0.7 of a share of common stock. The warrants are immediately exercisable at an exercise price of $0.75 per share and expire on February 21, 2018 and are subject to transfer restrictions.